Home  »  Markets   »  Organogenesis Holdings Inc. (ORGO) PE Ratio stood ...

Organogenesis Holdings Inc. (ORGO) PE Ratio stood at $46.57: Odds are Looking Good After Recent Activity

Organogenesis Holdings Inc. (NASDAQ: ORGO) open the trading on May 19, 2021, with great promise as it jumped 0.36% to $16.72. During the day, the stock rose to $17.045 and sunk to $15.70 before settling in for the price of $16.66 at the close. Taking a more long-term approach, ORGO posted a 52-week range of $3.14-$24.34.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Meanwhile, its Annual Earning per share during the time was 199.90%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 136.40%. This publicly-traded company’s shares outstanding now amounts to $127.87 million, simultaneously with a float of $32.99 million. The organization now has a market capitalization sitting at $2.03 billion. At the time of writing, stock’s 50-day Moving Average stood at $19.81, while the 200-day Moving Average is $9.97.

It is imperative to bring your focus towards the efficiency factor of the conglomerate that has a total of 910 employees. It has generated 371,756 per worker during the last fiscal year. Meanwhile, its income per employee was 19,724. The stock had 7.04 Receivables turnover and 1.31 Total Asset turnover. For the Profitability, stocks gross margin was +71.98, operating margin was +8.10 and Pretax Margin of +5.46.

Organogenesis Holdings Inc. (ORGO) Ownership Facts and Figures

Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Drug Manufacturers – Specialty & Generic industry. Organogenesis Holdings Inc.’s current insider ownership accounts for 54.10%, in contrast to 42.30% institutional ownership. According to the most recent insider trade that took place on Apr 09, this organization’s 10% Owner sold 20,000 shares at the rate of 22.11, making the entire transaction reach 442,200 in total value, affecting insider ownership by 20,000. Preceding that transaction, on Mar 01, Company’s 10% Owner sold 8,050 for 16.50, making the whole transaction’s value amount to 132,825. This particular insider is now the holder of 40,000 in total.

Organogenesis Holdings Inc. (ORGO) Earnings and Revenue Records

So, what does the last quarter earnings report of the company that was made public on 3/30/2021 suggests? It has posted $0.07 earnings per share (EPS) beating the forecaster’s viewpoint (set at -$0.02) by $0.09. This company achieved a net margin of +5.31 while generating a return on equity of 17.80. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.06 per share during the current fiscal year.

Organogenesis Holdings Inc.’s EPS increase for this current 12-month fiscal period is 136.40% and is forecasted to reach 0.42 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 44.46% through the next 5 years, which can be compared against the 199.90% growth it accomplished over the previous five years trading on the market.

Organogenesis Holdings Inc. (NASDAQ: ORGO) Trading Performance Indicators

Let’s observe the current performance indicators for Organogenesis Holdings Inc. (ORGO). It’s Quick Ratio in the last reported quarter now stands at 2.10. The Stock has managed to achieve an average true range (ATR) of 1.62. Alongside those numbers, its PE Ratio stands at $46.57, and its Beta score is 1.51. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 5.36. Similarly, its price to free cash flow for trailing twelve months is now 2904.26.

In the same vein, ORGO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.36, a figure that is expected to reach 0.05 in the next quarter, and analysts are predicting that it will be 0.42 at the market close of one year from today.

Technical Analysis of Organogenesis Holdings Inc. (ORGO)

[Organogenesis Holdings Inc., ORGO] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 8.39% While, its Average True Range was 1.62.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Raw Stochastic average of Organogenesis Holdings Inc. (ORGO) in the period of the previous 100 days is set at 57.54%, which indicates a major rise in contrast to 12.30% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 86.84% that was lower than 86.93% volatility it exhibited in the past 100-days period.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

Sign up for Our Newsletter Now! Discover which stocks to trade!
100% Free. Stop Anytime. No Spam